News & Media — Drug Delivery



6 Lessons I Learned from Attending PODD and the MidAtlantic Capital Conference
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

As the co-founder of Calla Lily Clinical Care, I’m always on the lookout for the latest trends and insights shaping healthcare. And also opportunities to escape my children. Did I mention I have 3 pre-teen/teenagers? Recently, I had the opportunity to attend two distinctly different conferences: PODD (Partnership Opportunities in Drug Delivery) in Boston and …

Funded MSc + PhD Studentship: Delivery of live biotherapeutics for restoration of women’s reproductive health

Calla Lily Clinical Care is delighted to partner with the University of Warwick for this fully funded (incl student stipend) four-year iCASE studentship from September 2025, available as part of Warwick’s MRC-funded Doctoral Training Partnership (DTP). Vaginal microbiota play a key role in women’s reproductive health. Disruption of the normal vaginal microbiome is associated with inflammation …

A Look at Three Common Medications That Can Be Delivered Intravaginally
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

When one thinks about yeast infections, menopause and fertility support, the conversation usually revolves around pills or injections. But there’s a better, more targeted way to achieve results. The era of blanket treatments is fading. I used to joke that medicine isn’t Burger King–you can’t just have it your way. Except, that’s exactly what is …

Professor Andy Lewis presents at PODD 2024 in Boston

We had a great 2 days at the Partnerships in Drug Delivery PODD Conference in Boston with team members Professor Andrew Lewis and Dr Lara Zibners representing Calla Lily.   Besides Andy’s well received presentation on our Callavid vaginal drug delivery platform, there were also superb connections made with the wider drug delivery technology community, and …

Why Intravaginal Drug Delivery Is the Future of Women’s Health
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

When we talk about advancements in healthcare, the vagina doesn’t often make it into the conversation. But it should. Hell, it’s standard dinner conversation at my house. The power of the vagina as a vessel for targeted, effective treatment is an emerging trend in women’s health. A trend geared toward smarter, safer, more effective medication …

Pitching at the Merck Innovation Challenge
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

Many of you know my drive to co-found Calla Lily Clinical Care was driven by my personal journey as a infertility survivor. The memory that remains particularly vivid is the distress caused by the inadequate methods of administering progesterone— whether through injections, pessaries, tablets, or suppositories. Each option (including now rings) has its pros and …

Callavid to be featured at PODD Conference

Excited to announce that Calla Lily Clinical Care will be attending the PODD Conference in Boston next week! Our Principal Scientist Andrew Lewis and co-founder Lara Zibners will be showcasing our innovative vaginal drug delivery platform and its numerous applications beginning with pregnancy and fertility, and exploring new partnership opportunities. Stay tuned for updates on …

Visit to MIT Center for Gynepathology Research
Thang Vo-Ta
CEO & Co-Founder

I had the great honour of meeting with Linda Griffith, Professor of Biological and Mechanical Engineering, and MacVicar Fellow at Massachusetts Institute of Technology, where she leads the MIT Center for Gynepathology Research. I’ve long been inspired by Professor Griffith’s groundbreaking work, and now, with our progress and dedicated team & lab resources in place, …

Highlighting Tommy’s – The Pregnancy and Baby Charity

Our team of experts at Calla Lily Clinical Care understands the challenges, questions, and emotions that come with the path to pregnancy. That’s why we are proud to highlight Tommy’s charity Tommy’s is a leading UK charity doing amazing work researching pregnancy complications and baby loss, including miscarriage, stillbirth, and premature birth. The charity’s work …

Progesterone for Miscarriage Reduction

Did you know that 3 years ago the UK became the first country in the world to recommend vaginally-administered 400mg progesterone to reduce miscarriages? It is estimated that 150,000 women each year in the UK should be taking progesterone, dubbed the “pregnancy hormone”, to reduce the risk of suffering a miscarriage. For those who didn’t …

당사는 웹사이트 경험을 향상시키기 위해 쿠키를 사용합니다. 당사는 웹사이트 기능이 올바로 구현되도록 만들고 보안을 유지하기 위해서 필요한 쿠키를 사용합니다. 이러한 쿠키를 항상 사용하도록 설정해야 합니다. “쿠키 수락”을 클릭하면 웹사이트 탐색을 개선하고 웹사이트 이용을 분석하고 마케팅 노력을 지원할 수 있도록 기기에 쿠키를 저장하는 것에 동의하게 됩니다. 자세한 내용은 개인 정보 보안 정책을 참조하십시오.